Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A Texas woman has filed a Lipitor lawsuit against Pfizer Inc., alleging its popular cholesterol-reducing drug caused her type-2 diabetes.
Plaintiff Mary B. started taking Lipitor in October 2009, according to her Lipitor diabetes lawsuit. In February 2010, she was diagnosed with type-2 diabetes.
Despite the diagnosis, Mary stayed on Lipitor until June 2012 when she learned of its association with type-2 diabetes.
The lawsuit alleges that Pfizer had the responsibility to warn Mary and other Lipitor consumers of all potential side effects. Mary insists that she never would have taken Lipitor if she had known about the potential of Lipitor diabetes.
The lawsuit, filed in a Lipitor MDL, accuses Pfizer of negligence, false advertising, concealing information, and misrepresenting a product.
This Lipitor lawsuit is filed In re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Products Liability Litigation, MDL 2502 in the United States District Court for the District of South Carolina, Charleston Division.
Overview of Lipitor Diabetes
Lipitor was approved over a decade ago to be a cholesterol-lowering medication and prevent heart disease in high-risk patients. Even with the release of generic versions of Lipitor, it still remains one of the most widely prescribed medications in the world.
Lipitor, as well as competitor Crestor, belong to a popular group of medications called statins that work by lowering the body’s so-called bad cholesterol. But numerous studies have found that Lipitor and other statins can trigger type-2 diabetes.
Medical experts theorize that statin drugs may impair certain hormones from the pancreas, which are primarily responsible for regulating insulin. Type-2 diabetes is caused by the insufficient amount of insulin in the body, which means that the body cannot properly convert food into energy.
This concern has become so widespread that the FDA released a public warning in 2012, requiring all statin safety labels to be updated to include type-2 diabetes.
While Pfizer did update Lipitor’s warning label, it did not specifically mention type-2 diabetes. Many have complained that the warning is ambiguous and insufficient.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Lipitor attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Lipitor class action lawsuit is best for you. [In general, Lipitor lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Lipitor Class Action Lawsuit Investigation
If you’re a woman who was diagnosed with type-2 diabetes while taking Lipitor, or were diagnosed with diabetes within 90 days or less of your last dose of Lipitor, you may be eligible for compensation. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.